Company Filing History:
Years Active: 2004
Title: Emiliana Borrelli: Innovator in Genetic Research
Introduction
Emiliana Borrelli is a prominent inventor based in Strasbourg, France. She has made significant contributions to the field of genetic research, particularly in the development of methods for manipulating cell populations. Her innovative work has implications for both therapeutic applications and the study of cellular processes.
Latest Patents
Emiliana Borrelli holds a patent for her invention titled "Inducible HSV-TK in transformed cell populations." This invention discloses a new selective method for inducibly and genetically ablating specific cell lineages in transgenic cell populations, such as in transgenic animals. The method allows for the production of stable transgenic perigees and enables control over both the timing and degree of cellular ablation. This innovation can be utilized for various therapeutic applications, as well as for studying cell lineages and organogenesis, including the regenerative capacity of residual stem cells. She has 1 patent to her name.
Career Highlights
Emiliana Borrelli is affiliated with the Salk Institute for Biological Studies, where she conducts her research. Her work has garnered attention for its potential to advance the understanding of genetic manipulation and its applications in medicine.
Collaborations
Emiliana has collaborated with notable scientists in her field, including Ronald Mark Evans and Richard Alan Heyman. These collaborations have further enriched her research and contributed to the advancement of genetic studies.
Conclusion
Emiliana Borrelli's innovative contributions to genetic research exemplify the impact of scientific inquiry on therapeutic advancements. Her work continues to inspire future research in the field of genetics.